Correction to: Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension

Katsuyoshi Suzuki; Naomi Otsuka; Hiroko Hizaki; Masayo Hashimoto; Yasuaki Kuwayama; Tafluprost/Timolol Versus Latanoprost/Timolol (TTVLT) Study Group

doi:10.1007/s12325-018-0864-0

Correction to: Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension

Adv Ther. 2019 Feb;36(2):492-494. doi: 10.1007/s12325-018-0864-0.

Authors

Katsuyoshi Suzuki¹, Naomi Otsuka², Hiroko Hizaki², Masayo Hashimoto², Yasuaki Kuwayama³; Tafluprost/Timolol Versus Latanoprost/Timolol (TTVLT) Study Group

Affiliations

¹ Suzuki Eye Clinic, Yamaguchi, Japan. suzuki_eye@grace.ocn.ne.jp.
² Santen Pharmaceutical Co., Ltd., Osaka, Japan.
³ Fukushima Eye Clinic, Osaka, Japan.

PMID: 30617814
DOI: 10.1007/s12325-018-0864-0

Abstract

In the original publication, the range to derive the P values is incorrectly represented in Table 2 and Table 3. The corrected tables are provided below.

Publication types

Published Erratum